| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945242 | Taiwanese Journal of Obstetrics and Gynecology | 2018 | 5 Pages |
Abstract
The cfDNA modalities have the advantages of higher detection rate for common trisomies and lower screening-positive rate. However, the cost of cfDNA testing needs to decrease significantly if it is to replace the current cFTS practice in a population of AMA on a purely cost effectiveness basis.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Min Pan, Lv-Yin Huang, Li Zhen, Dong-Zhi Li,